Hritvik Jain, Andrew M. Goldsweig/LinkedIn
Oct 29, 2025, 07:09
Hritvik Jain and Andrew Goldsweig Shared Risk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
Hritvik Jain, Founding President of EnigmaMed Research Initiative, shared a post on X:
“In our latest publication in The Canadian Journal of Cardiology (CJC), we report risk of MACCE, AMI, and readmission in IBD patients undergoing PCI! Thanks to Andrew M. Goldsweig guidance and mentorship”
Title: Outcomes of Percutaneous Coronary Intervention in Patients with Inflammatory Bowel Disease: A Propensity-Score Matched Analysis
Authors: Hritvik Jain, Nandan Patel, Jyoti Jain, Kriti Soni, Siddharth P. Agrawal, Bala Pushparaji, Richard Malone, Mohammed Absar Ullah, Andrew M. Goldsweig
Read full article here.
Stay informed with Hemostasis Today.
-
Dec 19, 2025, 13:30PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
-
Dec 19, 2025, 13:22If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
-
Dec 19, 2025, 12:52Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025